logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christoph Pöttgen

University Medicine Essen
H指数:29
被引数:3,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine learning models for adverse drug reaction prediction. A systematic review and three-level multilevel meta-analysis

机器学习模型用于药物不良反应预测：系统综述和三级多层元分析

Frontiers in Pharmacology
IF4.8
2026-09-150
OA
GC Giorgio Cappello; CO Christoph Oster; TS Teresa Schmidt; JG Jana Grieger; LJ Leon Jekel; KK Kathrin Kizina; YA Yahya Ahmadipour; LR Laurel Rauschenbach; PD Philipp Dammann; US Ulrich Sure; KK Kathy Keyvani; AJ Andreas Junker; LL Lazaros Lazaridis; MS Martin Stuschke; CP Christoph Pöttgen; BS Björn Scheffler; CK Christoph Kleinschnitz; SK Sied Kebir
A multicenter analysis of prognostic factors for patients undergoing re-irradiation for recurrent glioblastoma

多中心分析复发性胶质母细胞瘤再放疗患者的预后因素

Neuro-Oncology Advances
IF4.1
2026-09-020
OAAI
Niklas Benedikt Pepper; Maja Guberina; Christoph Pöttgen; Fabian Martin Troschel; Michael Oertel; Gerrit Fischedick; Lars Oliver Kiwitt; Cornelius Deuschl; Ramazan Jabbarli; Ulrich Sure; Philipp Dammann; Karsten Wrede; Sied Kebir; Andreas Junker; Michael Müther; Björn Scheffler; Oliver Grauer; Tanja Kuhlmann; Walter Stummer; Florian Padeberg; Hans Theodor Eich; Martin Stuschke; Nika Guberina; null
Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)

新诊断胶质母细胞瘤中肿瘤治疗电场在放疗前和放疗期间的安全性与可行性：PriCoTTF I/II期试验中Arm A可行性队列的结果

BMC Cancer
IF3.4
2026-07-270
OAAI
Sied Kebir; Christoph Oster; Sandeep Sharma; Leon Jekel; Teresa Schmidt; Jana Grieger; Giorgio Cappello; Kathrin Kizina; Lazaros Lazaridis; Laurèl Rauschenbach; Yahya Ahmadipour; Philipp Dammann; Andreas Junker; Kathy Keyvani; Jonas Feldheim; Daniela Pierscianek; Björn Scheffler; Martin Proescholdt; Peter Hau; Anca-Ligia Grosu; Dietmar Krex; Ulrich Sure; Christoph Kleinschnitz; Christoph Pöttgen; Martin Stuschke; Martin Glas
Phosphorylated mTOR immunohistochemistry–guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series

磷酸化mTOR免疫组化指导下的替西罗莫司在复发性IDH野生型胶质母细胞瘤中的应用：一项真实世界回顾性系列研究

Journal of Cancer Research and Clinical Oncology
IF2.8
2026-04-070
OAAI
Teresa Schmidt; Mavie Surau; Christoph Oster; Kathrin Kizina; Jana Grieger; Giorgio Cappello; Leon Jekel; Lazaros Lazaridis; Yahya Ahmadipour; Laurèl Rauschenbach; Nika Guberina; Christoph Pöttgen; Kathy Keyvani; Martin Stuschke; Christoph Kleinschnitz; Ulrich Sure; Andreas Junker; Martin Glas; Sied Kebir
Radiation Dose-Dependent and -Independent Pulmonary Infiltrates in Patients with High-Grade Pneumonitis After Radiochemotherapy and Durvalumab Consolidation for Stage III NSCLC

放疗剂量依赖性和非依赖性肺浸润：III期非小细胞肺癌患者在放化疗及度伐利尤单抗巩固治疗后发生重度肺炎的研究

Diagnostics
IF3.3
2026-03-110
OAAI
Andreas Herz; Aymane Khouya; Maja Guberina; Martin Metzenmacher; Marcel Opitz; Christoph Pöttgen; Gerrit Fischedick; Hubertus Hautzel; Thomas Gauler; Ken Herrmann; Erik Büscher; Servet Bölükbas; Fabian Doerr; Natalie Baldes; Laura Valentina Klüner; Benedikt M. Schaarschmidt; Rüdiger Karpf-Wissel; Jane Winantea; Denise Bos; Verena Jendrossek; Emil Mladenov; Lena Gockeln; Mario Andre Hetzel; Florian Wirsdörfer; Martin Schuler; Martin Stuschke; Nika Guberina
Ten-year Overall Survival in Resectable Stage-III NSCLC - Results of the Randomized ESPATUE Trial – Long-term Survival and Competing Risk Analysis
European Journal of Cancer
IF7.1
2026-02-040
PRE
Wilfried Ernst Erich Eberhardt; Christina Schulte; Christoph Pöttgen; Thomas Christoph Gauler; Godehard Friedel; Hans-Georg Kopp; Berthold Fischer; Heinz Schmidtberger; Martin Kimmich; Wilfried Budach; Sebastian Cordes; Martin Metzenmacher; Georg Zaun; Rodrigo Hepp de Los Rios; Werner Spengler; Claus Belka; Stephan Welter; Diana Luetke-Brintrup; Nika Guberina; Maja Guberina
O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial

O-(2-[18F]fluoroethyl)-L-tyrosine-PET引导与对比增强T1加权MRI引导的重复照射在复发性胶质母细胞瘤患者中的比较（GLIAA/NOA-10 ARO2013-01）：一项多中心、开放标签、随机试验

The Lancet Oncology
IF0
2025-12-190
OAAI
Anca-Ligia Grosu; Wolfgang A Weber; Erika Graf; Michael Mix; Ursula Nestle; Tanja Schimek-Jasch; Rolf Wiehle; Irina Mader; Urs Würtemberger; Karl-Josef Langen; Maximilian Niyazi; Frank Paulsen; Liane König; Frank Anton Giordano; Irina Spehl; Denise Bernhardt; Markus M Schymalla; Christoph Pöttgen; Sabine Semrau; Thomas Brunner
Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer

病理完全缓解预测III期非小细胞肺癌新辅助诱导化疗及放化疗后的长期生存率

THORACIC CANCER
IF2.3
2025-11-190
OAAI
Guberina, Maja; Metzenmacher, Martin; Pottgen, Christoph; Wiesweg, Marcel; Guberina, Nika; Merkel-jens, Anja; Lutke-brintrup, Diana; Bolukbas, Servet; Eberhardt, Wilfried E. E.; Stamatis, Georgios; Doerr, Fabian; Plones, Till; Hoffmann, Christian; Zaun, Gregor; Hoing, Benedikt; Kurten, Cornelius; Mladenov, Emil; Iliakis, George; Kersting, David; Fendler, Wolfgang P.; Gauler, Thomas; Opitz, Marcel; Milosevic, Aleksandar; Forsting, Michael; Nensa, Felix; Umutlu, Lale; Funke, Faustina; Hautzel, Hubertus; Herrmann, Ken; Taube, Christian; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin
[18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancer

[18F]FDG-PET/CT在评估Ⅱ期-Ⅲ期小细胞肺癌诱导化疗及同期放化疗期间肿瘤反应动力学中的应用

European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2025-11-170
OAAI
Christian Hoffmann; Hubertus Hautzel; Marcel Wiesweg; David Kersting; Nika Guberina; Christoph Pöttgen; Martin Metzenmacher; Martin Schuler; Thomas Gauler; Benedikt Höing; Cornelius Kürten; Fabian Doerr; Servet Bölükbas; Natalie Baldes; Marcel Opitz; Aleksandar Milosevic; Felix Nensa; Lale Umutlu; Faustina Funke; Wolfgang P. Fendler; Ken Herrmann; Martin Stuschke; Maja Guberina
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

新诊断胶质母细胞瘤患者中骨髓毒性的分布及预后意义：是否应更积极治疗？

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Oster, Christoph; Reineck, Pia; Schmidt, Teresa; Grieger, Jana; Sharma, Sandeep; Feldheim, Jonas; Kizina, Kathrin; Cappello, Giorgio; Jekel, Leon; Pabst, Kim M.; Ahmadipour, Yahya; Karadachi, Hanah; Rauschenbach, Laurel; Lazaridis, Lazaros; Guberina, Nika; Pottgen, Christoph; Blau, Tobias; Keyvani, Kathy; Scheffler, Bjorn; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Stuschke, Martin; Glas, Martin; Kebir, Sied
DISTRIBUTION AND PROGNOSTIC SIGNIFICANCE OF MYELOTOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA IN A REAL-LIFE COHORT: TIME TO TREAT MORE AGGRESSIVELY?

新诊断胶质母细胞瘤真实世界队列中骨髓毒性的分布及预后意义：是时候更积极治疗了吗？

NEURO-ONCOLOGY
IF13.4
2025-10-010
OAAI
Oster, C.; Reineck, P.; Schmidt, T.; Grieger, J.; Sharma, S.; Feldheim, J.; Kizina, K.; Cappello, G.; Pabst, K.; Ahmadipour, Y.; Karadachi, H.; Rauschenbach, L.; Lazaridis, L.; Guberina, N.; Blau, T.; Pottgen, C.; Keyvani, K.; Scheffler, B.; Herrmann, K.; Kleinschnitz, C.; Sure, U.; Stuschke, M.; Glas, M.; Kebir, S.
Outcome of systemic therapy in patients with advanced rare skin cancers: a retrospective multicenter DeCOG study of 209 patients

晚期罕见皮肤癌患者系统性治疗的结局：一项包含209名患者的回顾性多中心DeCOG研究

European Journal of Cancer
IF7.1
2025-08-300
PREAI
Selma Ugurel; Nessr Abu Rached; Thilo Gambichler; Miriam Mengoni; Thomas Tüting; Jessica C. Hassel; Robin Reschke; Georg C. Lodde; Jan-Malte Placke; Dirk Schadendorf; Lydia Reinhardt; Alexander Kreuter; Martin Gschnell; Jochen Utikal; Michael Erdmann; Pia Dücker; Doris Helbig; Cindy Franklin; Christoffer Gebhardt; Gabriela Poch; Katharina C. Kähler; Michael Weichenthal; Ralf Gutzmer; Lucie Heinzerling; Carsten Weishaupt; Peter Mohr; Kai-Martin Thoms; Berenice Lang; Bastian Schilling; Sebastian Haferkamp; Michael Sachse; Julia Welzel; Franziska Jochims; Ulrike Raap; Gaston Schley; Patrick Terheyden; Edgar Dippel; Christoph Pöttgen; Jürgen C. Becker; Alpaslan Tasdogan; Teresa Amaral; Lena Nanz; Ulrike Leiter
Decoding glioblastoma survival: unraveling the prognostic potential of olfactory function in a prospective observational study

解码胶质母细胞瘤生存：前瞻性观察性研究中嗅觉功能预后潜力的揭示

Neurological Research and Practice
IF3.2
2025-07-240
OAAI
Christoph Oster; Aylin Matyar; Teresa Schmidt; Thomas Hummel; Elke Hattingen; Martha Jokisch; Daniel Jokisch; Jana Grieger; Giorgio Cappello; Kathrin Kizina; Lazaros Lazaridis; Yahya Ahmadipour; Laurèl Rauschenbach; Martin Stuschke; Christoph Pöttgen; Nika Guberina; Tobias Tertel; Bernd Giebel; Gian Luca Dreizner; Francesco Barbato; Eva-Maria Skoda; Björn Scheffler; Michael Müther; Ken Herrmann; Christoph Kleinschnitz; Ulrich Sure; Cornelius Deuschl; Martin Glas; Sied Kebir
Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival

多发性乳腺癌脑转移的手术治疗：临床特征及影响术后生存的因素

JOURNAL OF NEURO-ONCOLOGY
IF3.1
2025-04-290
OA
Michel, Anna; Rauschenbach, Laurel; Karadachi, Hanah; Guemues, Meltem; Ahmadipour, Yahya; Oppong, Marvin Darkwah; Poettgen, Christoph; Hense, Joerg; Oezkan, Neriman; Wrede, Karsten H.; Dammann, Philipp; Sure, Ulrich; Jabbarli, Ramazan
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-08-281
OAAI
Schulte, Christina; Gauler, Thomas; Poettgen, Christoph; Friedel, Godehard; Kopp, Hans-Georg; Fischer, Berthold; Schmidberger, Heinz; Kimmich, Martin; Budach, Wilfried; Cordes, Sebastian; Wienker, Johannes; Metzenmacher, Martin; de los Rios, Rodrigo Hepp; Spengler, Werner; De Ruysscher, Dirk; Belka, Claus; Welter, Stefan; Luetke-Brintrup, Diana; Guberina, Maja; Oezkan, Filiz; Darwiche, Kaid; Schuler, Martin; Joeckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried Ernst Erich
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma

晚期黑色素瘤患者免疫检查点抑制和靶向治疗失败后，抗PD-(L)1联合BRAF/MEK抑制剂 (三联疗法)

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-05-012
OA
Albrecht, Lea Jessica; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C.; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B.; Varaljai, Renata; Lodde, Georg; Placke, Jan Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Roesch, Alexander; Schulz, Carsten; Berking, Carola; Poettgen, Christoph; Menzies, Alexander M.; Long, Georgina V.; Dummer, Reinhard; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa

研究方向

暂未获取到该数据
M
Martin Stuschke
H 指数:61论文数:806被引数:1.5万
M
Maja Guberina
H 指数:14论文数:94被引数:748
N
Nika Guberina
H 指数:23论文数:179被引数:1,593
W
Wilfried Eberhardt
H 指数:70论文数:497被引数:3.8万
T
Thomas Gauler
H 指数:43论文数:358被引数:1.2万
M
Martin Schüler
H 指数:86论文数:1,008被引数:4.4万
C
Clemens Aigner
H 指数:43论文数:523被引数:6,278
G
Georgios Stamatis
H 指数:44论文数:281被引数:6,149
M
Martin Metzenmacher
H 指数:14论文数:95被引数:844
D
Dirk De Ruysscher
H 指数:71论文数:442被引数:1.6万